PUBLIC COMPANY
saveEnveda Biosciences Inc
updated 11d ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
2Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- phase2ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- phase2Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- phase1Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis
🐶 Hiring Signal
Where Enveda Biosciences Inc is staffing up — a leading indicator of pipeline and commercial priorities.
departmentR&D / Discovery 2IT & Engineering 1
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that